Aegerion Pharmaceuticals Inc (NASDAQ:AEGR)

27.24
Delayed Data
As of 3:59pm ET
 +0.04 / +0.15%
Today’s Change
19.10
Today|||52-Week Range
58.08
+30.09%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Operating ActivitiesNet Income / Starting Line-39.5M-62.3M-63.4M--
 
 
 
 
Depreciation45.2K197.0K469.0K--
 
 
 
 
Total Other Cash Flow6.6M13.8M30.1M--
 
 
 
 
Funds From Operations-32.8M-48.3M-32.8M--
 
 
 
 
Funds From/For Other Operating Expenses-2.3M-5.7M5.7M--
 
 
 
 
Net Cash Flow - Operating Activities-30.5M-42.6M-38.5M--
 
 
 
 
 
InvestingIncrease In Investments-62.8M-54.4M-77.9M--
 
 
 
 
Decrease In Investments16.9M55.2M55.8M--
 
 
 
 
Capital Expenditures-631.3K-815.0K-716.0K--
 
 
 
 
Net Cash Flow Investing-46.5M-28.0K-22.8M--
 
 
 
 
 
FinancingShort Term Borrowings10.0M0.000.00--
 
 
Long Term Borrowings0.009.7M0.00--
 
 
Long Term Debt Reduction0.00-10.0M-3.0M--
 
 
 
Net Proceeds Stock Sale49.6M53.7M88.1M--
 
 
 
 
Common Preferred Redeemed0.000.000.00----
Common Dividends0.000.000.00----
Cash Dividends Paid - Total0.000.000.00----
Other Sources - Financing0.000.000.00----
Other Uses - Financing243.6K75.0K0.00--
 
 
 
Net Cash Flow - Financing59.3M53.4M85.0M--
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-24.9K8.0K-14.0K--
 
 
 
 
 
Net Change In Cash-17.7M10.8M23.7M0.00
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account